Oral tablets containing dapagliflozin, an SGLT2 inhibitor, formulated for type 2 diabetes management. Pharmaceutical manufacturers supply to wholesalers, hospitals, and retail pharmacies. Procurement by endocrinologists and diabetologists for use in clinical settings and patient care facilities.